We have previously shown that cd T cells traffic to the CNS during EAE with concurrently increased expression of b 2 -integrins and production of IFN-c and TNF-a. To extend these studies, we transferred bioluminescent cd T cells to WT mice and followed their movement through the acute stages of disease. We found that cd T cells rapidly migrated to the site of myelin oligodendrocyte glycoprotein peptide injection and underwent massive expansion. Within 6 days after EAE induction, bioluminescent cd T cells were found in the spinal cord and brain, peaking in number between days 10 and 12 and then rapidly declining by day 15. Reconstitution of cd T cell À/À mice with cd T cells derived from b 2 -integrin-deficient mice (CD11a, -b or -c) demonstrated that cd T-cell trafficking to the CNS during EAE is independent of this family of adhesion molecules. We also examined the role of cd T-cellproduced IFN-c and TNF-a in EAE and found that production of both cytokines by cd T cells was required for full development of EAE. These results indicate that cd T cells are critical for the development of EAE and suggest a therapeutic target in demyelinating disease.Key words: EAE/MS . Neuroimmunology . T cells . Transgenic/knockout mice Introduction gd T cells are one of several T-cell subsets that contribute to the development of EAE, a T-cell-mediated autoimmune disease of the CNS that mimics many aspects of the human disease MS [1][2][3]. Cellular infiltration of the brain and spinal cord by several leukocyte subsets, including gd T cells [4][5][6][7][8], is a characteristic feature of both EAE and MS [1,3]. Although it has been appreciated for some time that gd T cells produce cytokines that contribute to the pro-inflammatory milieu [9][10][11][12][13][14][15] and express adhesion molecules that may be critical for initial priming, trafficking to, and infiltration of the CNS [15][16][17], the significance of their contribution to demyelinating disease remains controversial.gd T cells are considered innate immune T cells by virtue of their limited T-cell receptor repertoire, tissue-specific homing patterns and recognition of non-traditional T-cell antigens [18][19][20][21]. Activation of gd T cells occurs on presentation of phosphoantigens, WC1 molecules or self-antigens by non-classical MHC molecules with cytokines and TLR providing co-stimulation [22][23][24][25][26][27][28][29][30]. Regardless of the priming event(s), trafficking mechanisms employed by gd T cells in demyelinating disease remain ill-defined. Studies have implicated VLA-4 as a participant in gd T-cell adhesion to endothelium, epithelium or fibroblasts, and in transmigration [16,17,31,32], but none have implicated VLA-4 in migration of gd T cells to the CNS. In contrast, gd T cells express all four members of the b 2 -integrin family of adhesion molecules and expression increases through the course of myelin oligodendrocyte glycoprotein (MOG)-induced EAE [15]. Importantly, deletion of three of the four b 2 -integrins (CD11a-c) results in significantly attenuate...